3.1.1.3 Selective beta2-agonists (short-acting)
All strengths are expressed 'per dose'.
For Kent and Medway Guidance for Primary Care Management of COPD click here
Generic prescribing of inhalers should be avoided as this might lead to patients being given an unfamiliar inhaler device which they are not able to use properly. Different products and doses are licensed for different age groups and some may be applicable only to older children or adults (aged 18 years and over). Prior to prescribing, the relevant Summary of Product Characteristics (SPC) should be checked.
Link to MHRA alert https://www.gov.uk/drug-safety-update/pressurised-metered-dose-inhalers-pmdi-risk-of-airway-obstruction-from-aspiration-of-loose-objects.
Expand All / Expand All (incl. cost)
Where appropriate dry powder inhalers should be selected as the first line salbutamol product for all patients over the age of 4 years. The patient will require robust inhaler technique training.
https://www.rightbreathe.com/
NOTE: Ventolin Evohaler emits 28kg CO2e per inhaler. Salamol only emits 12kg Co2e, and dry powder inhalers are almost carbon neutral.
| Pack | Price |
|---|---|
| 200 dose | £1.46 |
| Pack | Price |
|---|---|
| 200 dose | £3.31 |
| Pack | Price |
|---|---|
| 60 dose | £1.99 |
| Pack | Price |
|---|---|
| 150 ml | £1.50 |
| Pack | Price |
|---|---|
| 20 unit dose | £15.94 |
| 5 unit dose |
| Pack | Price |
|---|---|
| 20 unit dose | £16.69 |
| 5 unit dose |